TY - BOOK PY - 2015 DA - 2015// TI - Underlying Cause of Death 1999-2013 on CDC WONDER Online Database ID - ref1 ER - TY - JOUR AU - Karalis, D. G. PY - 2009 DA - 2009// TI - Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery disease JO - Mayo Clin Proc VL - 84 UR - https://doi.org/10.1016/S0025-6196(11)60544-2 DO - 10.1016/S0025-6196(11)60544-2 ID - Karalis2009 ER - TY - JOUR AU - Liao, J. K. AU - Laufs, U. PY - 2005 DA - 2005// TI - PLEIOTROPIC EFFECTS OF STATINS JO - Annu Rev Pharmacol Toxicol VL - 45 UR - https://doi.org/10.1146/annurev.pharmtox.45.120403.095748 DO - 10.1146/annurev.pharmtox.45.120403.095748 ID - Liao2005 ER - TY - BOOK PY - 2017 DA - 2017// TI - The GoodRx Top 10 ID - ref4 ER - TY - STD TI - Tuohy CV, Dodson J. Statins for Primary Prevention in Older Adults. Am J Cardiol. 2015; ID - ref5 ER - TY - JOUR AU - Ott, B. R. AU - Daiello, L. A. AU - Dahabreh, I. J. AU - Springate, B. A. AU - Bixby, K. AU - Murali, M. PY - 2015 DA - 2015// TI - Do Statins Impair Cognition? A Systematic Review and Meta-Analysis of Randomized Controlled Trials JO - J Gen Intern Med VL - 30 UR - https://doi.org/10.1007/s11606-014-3115-3 DO - 10.1007/s11606-014-3115-3 ID - Ott2015 ER - TY - STD TI - U.S. Food and Drug Administration. FDA Consumer Health Information: FDA Expands Advice on Statin Risks. 2012. www.fda.gov/consumer. UR - http://www.fda.gov/consumer ID - ref7 ER - TY - JOUR AU - Hammer, G. P. AU - du Prel, J. -. B. AU - Blettner, M. PY - 2009 DA - 2009// TI - Avoiding bias in observational studies: part 8 in a series of articles on evaluation of scientific publications JO - Dtsch Arztebl Int VL - 106 ID - Hammer2009 ER - TY - JOUR AU - Shepherd, J. AU - Blauw, G. J. AU - Murphy, M. B. AU - Bollen, E. L. E. M. AU - Buckley, B. M. AU - Cobbe, S. M. PY - 2002 DA - 2002// TI - Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)11600-X DO - 10.1016/S0140-6736(02)11600-X ID - Shepherd2002 ER - TY - JOUR AU - Mora, S. AU - Ridker, P. M. PY - 2006 DA - 2006// TI - Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? JO - Am J Cardiol VL - 97 UR - https://doi.org/10.1016/j.amjcard.2005.11.014 DO - 10.1016/j.amjcard.2005.11.014 ID - Mora2006 ER - TY - JOUR PY - 2002 DA - 2002// TI - MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)09327-3 DO - 10.1016/S0140-6736(02)09327-3 ID - ref11 ER - TY - STD TI - Mcguinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2016; ID - ref12 ER - TY - JOUR AU - Posvar, E. L. AU - Radulovic, L. L. AU - Cilla, D. D. AU - Whitfield, L. R. AU - Sedman, A. J. PY - 1996 DA - 1996// TI - Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects JO - J Clin Pharmacol VL - 36 UR - https://doi.org/10.1002/j.1552-4604.1996.tb04242.x DO - 10.1002/j.1552-4604.1996.tb04242.x ID - Posvar1996 ER - TY - JOUR AU - Wagstaff, L. R. AU - Mitton, M. W. AU - Arvik, B. M. AU - Doraiswamy, P. M. PY - 2003 DA - 2003// TI - Statin-Associated Memory Loss: Analysis of 60 Case Reports and Review of the Literature JO - Pharmacotherapy VL - 23 UR - https://doi.org/10.1592/phco.23.7.871.32720 DO - 10.1592/phco.23.7.871.32720 ID - Wagstaff2003 ER - TY - JOUR AU - Muldoon, M. F. AU - Barger, S. D. AU - Ryan, C. M. AU - Flory, J. D. AU - Lehoczky, J. P. AU - Matthews, K. A. PY - 2000 DA - 2000// TI - Effects of lovastatin on cognitive function and psychological well-being JO - Am J Med VL - 108 UR - https://doi.org/10.1016/S0002-9343(00)00353-3 DO - 10.1016/S0002-9343(00)00353-3 ID - Muldoon2000 ER - TY - JOUR AU - Muldoon, M. F. AU - Ryan, C. M. AU - Sereika, S. M. AU - Flory, J. D. AU - Manuck, S. B. PY - 2004 DA - 2004// TI - Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults JO - Am J Med VL - 117 UR - https://doi.org/10.1016/j.amjmed.2004.07.041 DO - 10.1016/j.amjmed.2004.07.041 ID - Muldoon2004 ER - TY - JOUR AU - Evans, M. A. AU - Golomb, B. A. PY - 2009 DA - 2009// TI - Statin-Associated Adverse Cognitive Effects: Survey Results from 171 Patients JO - Pharmacotherapy VL - 29 UR - https://doi.org/10.1592/phco.29.7.800 DO - 10.1592/phco.29.7.800 ID - Evans2009 ER - TY - JOUR AU - Naranjo, C. A. AU - Busto, U. AU - Sellers, E. M. AU - Sandor, P. AU - Ruiz, I. AU - Roberts, E. A. PY - 1981 DA - 1981// TI - A method for estimating the probability of adverse drug reactions JO - Clin Pharmacol Ther VL - 30 UR - https://doi.org/10.1038/clpt.1981.154 DO - 10.1038/clpt.1981.154 ID - Naranjo1981 ER - TY - JOUR AU - Sahebzamani, F. M. AU - Munro, C. L. AU - Marroquin, O. C. AU - Diamond, D. M. AU - Keller, E. PY - 2014 DA - 2014// TI - Examination of the FDA Warning for Statins and Cognitive Dysfunction JO - Aust J Pharm VL - 2 ID - Sahebzamani2014 ER - TY - JOUR AU - Cham, S. AU - Koslik, H. J. AU - Golomb, B. A. PY - 2016 DA - 2016// TI - Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series JO - Drug Saf Case Rep VL - 3 UR - https://doi.org/10.1007/s40800-015-0024-2 DO - 10.1007/s40800-015-0024-2 ID - Cham2016 ER - TY - JOUR AU - Suraweera, C. AU - de Silva, V. AU - Hanwella, R. PY - 2016 DA - 2016// TI - Simvastatin-induced cognitive dysfunction: two case reports JO - J Med Case Rep VL - 10 UR - https://doi.org/10.1186/s13256-016-0877-8 DO - 10.1186/s13256-016-0877-8 ID - Suraweera2016 ER - TY - JOUR AU - Richardson, K. AU - Schoen, M. AU - French, B. AU - Umscheid, C. A. AU - Mitchell, M. D. AU - Arnold, S. E. PY - 2013 DA - 2013// TI - Statins and cognitive function: a systematic review JO - Ann Intern Med VL - 159 UR - https://doi.org/10.7326/0003-4819-159-10-201311190-00007 DO - 10.7326/0003-4819-159-10-201311190-00007 ID - Richardson2013 ER - TY - JOUR AU - Benito-León, J. AU - Louis, E. D. AU - Vega, S. AU - Bermejo-Pareja, F. PY - 2010 DA - 2010// TI - Statins and cognitive functioning in the elderly: A population-based study JO - J Alzheimers Dis VL - 21 UR - https://doi.org/10.3233/JAD-2010-100180 DO - 10.3233/JAD-2010-100180 ID - Benito-León2010 ER - TY - JOUR AU - Lilly, S. M. AU - Mortensen, E. M. AU - Frei, C. R. AU - Pugh, M. J. AU - Mansi, I. A. PY - 2014 DA - 2014// TI - Comparison of the risk of psychological and cognitive disorders between persistent and nonpersistent statin users JO - Am J Cardiol VL - 114 UR - https://doi.org/10.1016/j.amjcard.2014.07.010 DO - 10.1016/j.amjcard.2014.07.010 ID - Lilly2014 ER - TY - JOUR AU - Swiger, K. J. AU - Manalac, R. J. AU - Blumenthal, R. S. AU - Blaha, M. J. AU - Martin, S. S. PY - 2013 DA - 2013// TI - Statins and cognition: A systematic review and meta-analysis of short- and long-term cognitive effects JO - Mayo Clin Proc VL - 88 UR - https://doi.org/10.1016/j.mayocp.2013.07.013 DO - 10.1016/j.mayocp.2013.07.013 ID - Swiger2013 ER - TY - JOUR AU - Stone, N. J. AU - Robinson, J. G. AU - Lichtenstein, A. H. AU - Bairey Merz, C. N. AU - Blum, C. B. AU - Eckel, R. H. PY - 2014 DA - 2014// TI - 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults JO - Circulation VL - 129 UR - https://doi.org/10.1161/01.cir.0000437738.63853.7a DO - 10.1161/01.cir.0000437738.63853.7a ID - Stone2014 ER - TY - JOUR AU - Bernstein, A. B. AU - Remsburg, R. E. PY - 2007 DA - 2007// TI - Estimated Prevalence of People with Cognitive Impairment: Results from Nationally Representative Community and Institutional Surveys JO - Gerontologist VL - 47 UR - https://doi.org/10.1093/geront/47.3.350 DO - 10.1093/geront/47.3.350 ID - Bernstein2007 ER - TY - JOUR AU - Saheki, A. AU - Terasaki, T. AU - Tamai, I. AU - Tsuji, A. PY - 1994 DA - 1994// TI - In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors JO - Pharm Res VL - 11 UR - https://doi.org/10.1023/A:1018975928974 DO - 10.1023/A:1018975928974 ID - Saheki1994 ER - TY - JOUR AU - Golomb, B. A. AU - Criqui, M. H. AU - White, H. L. AU - Dimsdale, J. E. PY - 2004 DA - 2004// TI - The UCSD Statin Study: A randomized controlled trial assessing the impact of statins on selected noncardiac outcomes JO - Control Clin Trials VL - 25 UR - https://doi.org/10.1016/j.cct.2003.08.014 DO - 10.1016/j.cct.2003.08.014 ID - Golomb2004 ER - TY - JOUR AU - Nissen, S. AU - Nicholls, S. AU - Sipahi, I. AU - Libby, P. AU - Raichlen, J. S. AU - Ballantyne, C. M. PY - 2006 DA - 2006// TI - Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.13.jpc60002 DO - 10.1001/jama.295.13.jpc60002 ID - Nissen2006 ER - TY - STD TI - Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009:453–63. ID - ref31 ER - TY - JOUR AU - Wolozin, B. AU - Kellman, W. AU - Ruosseau, P. AU - Celesia, G. G. AU - Siegel, G. PY - 2000 DA - 2000// TI - Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors JO - Arch Neurol VL - 57 UR - https://doi.org/10.1001/archneur.57.10.1439 DO - 10.1001/archneur.57.10.1439 ID - Wolozin2000 ER - TY - JOUR AU - Jick, H. AU - Zornberg, G. L. AU - Jick, S. S. AU - Seshadri, S. AU - Drachman, D. A. PY - 2000 DA - 2000// TI - Statins and the risk of dementia JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)03155-X DO - 10.1016/S0140-6736(00)03155-X ID - Jick2000 ER - TY - STD TI - Shah NP, Swiger KJ, Martin SS. Impact on Cognitive Function—Are All Statins the Same? Curr Atheroscler Rep. 2015:1–7. ID - ref34 ER - TY - JOUR AU - Wong, W. B. AU - Lin, V. W. AU - Boudreau, D. AU - Devine, E. B. PY - 2013 DA - 2013// TI - Statins in the prevention of dementia and Alzheimer’s disease: A meta-analysis of observational studies and an assessment of confounding JO - Pharmacoepidemiol Drug Saf VL - 22 UR - https://doi.org/10.1002/pds.3381 DO - 10.1002/pds.3381 ID - Wong2013 ER - TY - STD TI - Chatterjee S, Krishnamoorthy P, Ranjan P, Roy A, Chakraborty A, Sabharwal MS, et al. Statins and cognitive function: an updated review. Curr Cardiol Rep. 2015:4. ID - ref36 ER - TY - JOUR AU - Simons, M. AU - Schwärzler, F. AU - Lütjohann, D. AU - Von Bergmann, K. AU - Beyreuther, K. AU - Dichgans, J. PY - 2002 DA - 2002// TI - Treatment with simvastatin in normocholesterolemic patients with Alzheimer’s disease: A 26-week randomized, placebo-controlled, double-blind trial JO - Ann Neurol VL - 52 UR - https://doi.org/10.1002/ana.10292 DO - 10.1002/ana.10292 ID - Simons2002 ER - TY - JOUR AU - Li, G. AU - Shofer, J. B. AU - Rhew, I. C. AU - Kukull, W. A. AU - Peskind, E. R. AU - McCormick, W. PY - 2010 DA - 2010// TI - Age-varying association between statin use and incident Alzheimer’s disease JO - J Am Geriatr Soc VL - 58 UR - https://doi.org/10.1111/j.1532-5415.2010.02906.x DO - 10.1111/j.1532-5415.2010.02906.x ID - Li2010 ER - TY - JOUR AU - Rockwood, K. AU - Kirkland, S. AU - Hogan, D. B. AU - MacKnight, C. AU - Merry, H. AU - Verreault, R. PY - 2002 DA - 2002// TI - Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people JO - Arch Neurol VL - 59 UR - https://doi.org/10.1001/archneur.59.2.223 DO - 10.1001/archneur.59.2.223 ID - Rockwood2002 ER - TY - JOUR AU - Green, R. C. AU - McNagny, S. E. AU - Jayakumar, P. AU - Cupples, L. A. AU - Benke, K. AU - Farrer, L. A. PY - 2006 DA - 2006// TI - Statin use and the risk of Alzheimer’s disease: The MIRAGE Study JO - Alzheimers Dement VL - 2 UR - https://doi.org/10.1016/j.jalz.2006.02.003 DO - 10.1016/j.jalz.2006.02.003 ID - Green2006 ER - TY - JOUR AU - Pfefferkorn, J. A. AU - Song, Y. AU - Sun, K. L. AU - Miller, S. R. AU - Trivedi, B. K. AU - Choi, C. PY - 2007 DA - 2007// TI - Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors. Bioorganic JO - Med Chem Lett VL - 17 UR - https://doi.org/10.1016/j.bmcl.2007.05.096 DO - 10.1016/j.bmcl.2007.05.096 ID - Pfefferkorn2007 ER - TY - JOUR AU - Zissimopoulos, J. M. AU - Barthold, D. AU - Brinton, R. D. AU - Joyce, G. PY - 2017 DA - 2017// TI - Sex and race differences in the association between statin use and the incidence of Alzheimer disease JO - JAMA Neurol VL - 74 UR - https://doi.org/10.1001/jamaneurol.2016.3783 DO - 10.1001/jamaneurol.2016.3783 ID - Zissimopoulos2017 ER - TY - JOUR AU - Geifman, N. AU - Brinton, R. D. AU - Kennedy, R. E. AU - Schneider, L. S. AU - Butte, A. J. PY - 2017 DA - 2017// TI - Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease JO - Alzheimers Res Ther VL - 9 UR - https://doi.org/10.1186/s13195-017-0237-y DO - 10.1186/s13195-017-0237-y ID - Geifman2017 ER - TY - JOUR AU - Sparks, D. AU - Kryscio, R. AU - Sabbagh, M. AU - Connor, D. AU - Sparks, L. AU - Liebsack, C. PY - 2008 DA - 2008// TI - Reduced risk of incidenct AD with elective statin use in a clinical trial cohort JO - Curr Alzheimer Res VL - 5 UR - https://doi.org/10.2174/156720508785132316 DO - 10.2174/156720508785132316 ID - Sparks2008 ER - TY - JOUR AU - Shepardson, N. AU - Shankar, G. AU - Selkoe, D. PY - 2011 DA - 2011// TI - Cholesterol Level and Statin Use in Alzheimer Disease JO - Arch Neurol VL - 68 UR - https://doi.org/10.1001/archneurol.2011.242 DO - 10.1001/archneurol.2011.242 ID - Shepardson2011 ER - TY - JOUR AU - Power, M. AU - Rawlings, A. AU - Sharrett, A. AU - Bandeen-Roche, K. AU - Coresh, J. AU - Ballantyne, C. PY - 2017 DA - 2017// TI - Association of midlife lipids with 20-year cognitive change: A cohort study JO - Alzheimers Dement VL - S1552-5260 ID - Power2017 ER - TY - JOUR AU - Anstey, K. J. AU - Ashby-Mitchell, K. AU - Peters, R. PY - 2017 DA - 2017// TI - Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis JO - J Alzheimers Dis VL - 56 UR - https://doi.org/10.3233/JAD-160826 DO - 10.3233/JAD-160826 ID - Anstey2017 ER - TY - STD TI - Schilling S, Tzourio C, Soumaré A, Kaffashian S, Dartigues JF, Ancelin ML, et al. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study. PLoS Med. 2017;14 ID - ref48 ER - TY - JOUR AU - Morris, J. C. PY - 1993 DA - 1993// TI - The Clinical Dementia Rating (CDR): Current version and scoring rules JO - Neurology VL - 43 UR - https://doi.org/10.1212/WNL.43.11.2412-a DO - 10.1212/WNL.43.11.2412-a ID - Morris1993 ER - TY - JOUR AU - Sinyavskaya, L. AU - Gauthier, S. AU - Renoux, C. AU - Dell’Aniello, S. AU - Suissa, S. AU - Brassard, P. PY - 2018 DA - 2018// TI - Comparative effect of statins on the risk of incident Alzheimer disease JO - Neurology VL - 90 UR - https://doi.org/10.1212/WNL.0000000000004818 DO - 10.1212/WNL.0000000000004818 ID - Sinyavskaya2018 ER - TY - JOUR AU - Houx, P. J. AU - Shepherd, J. AU - Blauw, G. -. J. AU - Murphy, M. B. AU - Ford, I. AU - Bollen, E. L. PY - 2002 DA - 2002// TI - Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk JO - J Neurol Neurosurg Psychiatry VL - 73 UR - https://doi.org/10.1136/jnnp.73.4.385 DO - 10.1136/jnnp.73.4.385 ID - Houx2002 ER - TY - JOUR AU - Appleton, J. P. AU - Scutt, P. AU - Sprigg, N. AU - Bath, P. M. PY - 2017 DA - 2017// TI - Hypercholesterolaemia and vascular dementia JO - Clin Sci VL - 131 UR - https://doi.org/10.1042/CS20160382 DO - 10.1042/CS20160382 ID - Appleton2017 ER - TY - STD TI - Orth M, Bellosta S. Cholesterol: Its regulation and role in central nervous system disorders. Cholesterol. 2012; ID - ref53 ER - TY - JOUR AU - Banks, W. A. PY - 2009 DA - 2009// TI - Characteristics of compounds that cross the blood-brain barrier JO - BMC Neurol VL - 9 UR - https://doi.org/10.1186/1471-2377-9-S1-S3 DO - 10.1186/1471-2377-9-S1-S3 ID - Banks2009 ER - TY - JOUR AU - Pardridge, W. M. PY - 2012 DA - 2012// TI - Drug transport across the blood-brain barrier JO - J Cereb Blood Flow Metab VL - 32 UR - https://doi.org/10.1038/jcbfm.2012.126 DO - 10.1038/jcbfm.2012.126 ID - Pardridge2012 ER - TY - JOUR AU - Canestaro, W. J. AU - Austin, M. A. AU - Thummel, K. E. PY - 2014 DA - 2014// TI - Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review JO - Genet Med VL - 16 UR - https://doi.org/10.1038/gim.2014.41 DO - 10.1038/gim.2014.41 ID - Canestaro2014 ER - TY - JOUR AU - Kim, M. C. AU - Ahn, Y. AU - Jang, S. Y. AU - Cho, K. H. AU - Hwang, S. H. AU - Lee, M. G. PY - 2011 DA - 2011// TI - Comparison of Clinical Outcomes of Hydrophilic and Lipophilic Statins in Patients with Acute Myocardial Infarction JO - Korean J Intern Med VL - 26 UR - https://doi.org/10.3904/kjim.2011.26.3.294 DO - 10.3904/kjim.2011.26.3.294 ID - Kim2011 ER - TY - JOUR AU - Hamelin, B. PY - 1998 DA - 1998// TI - Hydrophilicity/ lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors JO - Trends Pharmacol Sci VL - 19 UR - https://doi.org/10.1016/S0165-6147(97)01147-4 DO - 10.1016/S0165-6147(97)01147-4 ID - Hamelin1998 ER - TY - STD TI - Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: An update. Fundam Clin Pharmacol. 2005:117–25. ID - ref59 ER - TY - JOUR AU - Corsini, A. AU - Bellosta, S. AU - Baetta, R. AU - Fumagalli, R. AU - Paoletti, R. AU - Bernini, F. PY - 1999 DA - 1999// TI - New insights into the pharmacodynamic and pharmacokinetic properties of statins JO - Pharmacol Ther VL - 84 UR - https://doi.org/10.1016/S0163-7258(99)00045-5 DO - 10.1016/S0163-7258(99)00045-5 ID - Corsini1999 ER - TY - JOUR AU - White, C. M. PY - 2002 DA - 2002// TI - A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin JO - J Clin Pharmacol VL - 42 UR - https://doi.org/10.1177/0091270002042009002 DO - 10.1177/0091270002042009002 ID - White2002 ER - TY - JOUR AU - Engelberg, H. PY - 1992 DA - 1992// TI - Low serum cholesterol and suicide JO - Lancet VL - 339 UR - https://doi.org/10.1016/0140-6736(92)90609-7 DO - 10.1016/0140-6736(92)90609-7 ID - Engelberg1992 ER - TY - JOUR AU - Martin, M. G. AU - Pfrieger, F. AU - Dotti, C. G. PY - 2014 DA - 2014// TI - Cholesterol in brain disease: sometimes determinant and frequently implicated JO - EMBO Rep VL - 15 UR - https://doi.org/10.15252/embr.201439225 DO - 10.15252/embr.201439225 ID - Martin2014 ER - TY - JOUR AU - Golomb, B. A. AU - Evans, M. A. PY - 2008 DA - 2008// TI - Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism JO - Am J Cardiovasc Drugs VL - 8 UR - https://doi.org/10.2165/0129784-200808060-00004 DO - 10.2165/0129784-200808060-00004 ID - Golomb2008 ER - TY - JOUR AU - De Vivo, D. C. AU - DiMauro, S. PY - 1990 DA - 1990// TI - Mitochondrial defects of brain and muscle JO - Biol Neonate VL - 58 UR - https://doi.org/10.1159/000243300 DO - 10.1159/000243300 ID - De Vivo1990 ER - TY - JOUR AU - Law, M. R. AU - Wald, N. J. AU - Rudnicka, A. R. PY - 2003 DA - 2003// TI - Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis JO - BMJ VL - 326 UR - https://doi.org/10.1136/bmj.326.7404.1423 DO - 10.1136/bmj.326.7404.1423 ID - Law2003 ER - TY - JOUR AU - Ostrowski, S. M. AU - Wilkinson, B. L. AU - Golde, T. E. AU - Landreth, G. PY - 2007 DA - 2007// TI - Statins reduce amyloid-?? Production through inhibition of protein isoprenylation JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M702640200 DO - 10.1074/jbc.M702640200 ID - Ostrowski2007 ER - TY - JOUR AU - Leduc, V. AU - De Beaumont, L. AU - Theroux, L. AU - Dea, D. AU - Aisen, P. AU - Petersen, R. C. PY - 2015 DA - 2015// TI - HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer’s disease in a three cohorts study JO - Mol Psychiatry VL - 20 UR - https://doi.org/10.1038/mp.2014.81 DO - 10.1038/mp.2014.81 ID - Leduc2015 ER - TY - JOUR AU - Refolo, L. M. AU - Pappolla, M. A. AU - LaFrancois, J. AU - Malester, B. AU - Schmidt, S. D. AU - Thomas-Bryant, T. PY - 2001 DA - 2001// TI - A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer’s Disease JO - Neurobiol Dis VL - 8 UR - https://doi.org/10.1006/nbdi.2001.0422 DO - 10.1006/nbdi.2001.0422 ID - Refolo2001 ER - TY - JOUR AU - Zhang, Y. AU - Fan, Y. AU - Wang, M. AU - Wang, D. AU - Li, X. PY - 2013 DA - 2013// TI - Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease JO - Clin Interv Aging VL - 8 ID - Zhang2013 ER - TY - JOUR AU - Hooff, G. AU - Wood, W. AU - Muller, W. AU - Eckert, G. PY - 2010 DA - 2010// TI - Isoprenoids, Small GTPases and Alzheimer’s Disease JO - Biochim Biophys Acta VL - 1801 UR - https://doi.org/10.1016/j.bbalip.2010.03.014 DO - 10.1016/j.bbalip.2010.03.014 ID - Hooff2010 ER - TY - JOUR AU - Wood, W. G. AU - Mΰller, W. E. AU - Eckert, G. P. PY - 2014 DA - 2014// TI - Statins and Neuroprotection: Basic Pharmacology Needed JO - Mol Neurobiol VL - 50 UR - https://doi.org/10.1007/s12035-014-8647-3 DO - 10.1007/s12035-014-8647-3 ID - Wood2014 ER - TY - JOUR PY - 2016 DA - 2016// TI - 2016 Alzheimer’s Disease Facts and Figures JO - Alzheimers Dement VL - 12 UR - https://doi.org/10.1016/S1552-5260(16)33076-X DO - 10.1016/S1552-5260(16)33076-X ID - ref73 ER - TY - JOUR AU - Van Aelst, L. AU - D’Souza-Schorey, C. PY - 1997 DA - 1997// TI - Rho GTPases and signaling networks JO - Genes Dev VL - 11 UR - https://doi.org/10.1101/gad.11.18.2295 DO - 10.1101/gad.11.18.2295 ID - Van Aelst1997 ER -